Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
DTI's 2025 earnings narrative sheds light on demand for drilling tools and oilfield equipment. This guide breaks down...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
As JBL gears up for its 2026 earnings season, this guide breaks down what to expect from the Q2 call, how to read the...
BuzzFeed shares surged after news that Byron Allen’s family office will take a majority stake. The move could reshape...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
Digital Turbine APPS reported Q1 2026 results that highlighted continued monetization momentum and strategic partners...
A practical, reader-friendly guide to interpreting Xunlei's Q1 2026 earnings. Learn what to watch, how to model resul...
If you’re worried about crash artificial headlines in AI stocks, a simple, cost-efficient solution can help: diversif...